激活素受体样激酶5 （ALK5）抑制剂：专利审查（2013年至今）。

已完结 10 由 Lee930217 发布于 2026/6/23 16:09:45

DOI:10.1080/13543776.2026.2660906
作者：Xin-Yi Huang,?Chao-Qun Yu,?Xin Wang,?Zhen Guo,?Cheng-Hua Jin
文献类型：期刊论文
补充材料：只需要正文

Taylor & Francis

Abstract：Introduction: Activin receptor-like kinase 5 (ALK5) is a pivotal component of the transforming growth factor β (TGF-β) signaling pathway. Currently, 10 ALK5 inhibitors are under clinical inv

应助信息

3小时前

Book学术机器人

6672554d3bd611f1a93434735aa3bc31.pdf 已采纳

3小时前

Book学术机器人

2026/6/23 16:09:45 Book学术AI机器人已找到文献并上传

2026/6/23 16:09:45 Book学术AI机器人收到请求，开始寻找文献

2026/6/23 16:09:45 已向机器人发送请求

3小时前

Lee930217 发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:American Chemical Society (ACS)Continuous Synthesis of 1,3,2-Dioxathiolane 2,2-Dioxide (DTD) by Hydrogen Peroxide with Titanium Silicalite-1 Catalyst Using a Fixed-Bed Reactor